drugset / Trial / NCT00694928

Vaginal Infection Study 2

NCT00694928

Phase 3 Completed 843 enrolled Lumara Health, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will evaluate the efficacy and safety of a vaginal product compared with that of another vaginal product in the treatment of vaginal infections.

Timeline

Start
2008-05
Primary completion
2009-11
Completion
2009-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Butoconazole Small molecule
Subject Clindamycin Unknown

Indications